Inventor · disambiguated record
Yasuyuki Igarashi
Also filed as: IGARASHI YASUYUKI
16 granted patents·4 pending applications·563 citations·filing 1990–2024
95Inventor score
Top patents by PatentIndex Score
20 records- 0193US5151360AEffect of n,n,n-trimethylsphingosine on protein kinase-c activity, melanoma cell growth in vitro, metastatic potential in vivo and human platelet aggregationBIOMEMBRANE INST·Filed 1991·Granted Sep 29, 1992·126 cites·6 claims
- 0292US5391800AMethod for inhibition of cell motility by sphingosine-1-phosphate, its derivatives and mimetics and method of synthesizing sphingosine-1-phosphate and its derivativesBIOMEMBRANE INST·Filed 1993·Granted Feb 21, 1995·51 cites·9 claims
- 0392US5260288AMethod for inhibition of cell motility by sphingosine-1-phosphate and derivativesBIOMEMBRANE INST·Filed 1992·Granted Nov 9, 1993·51 cites·12 claims
- 0492US5137919AEffect of N,N,N,-trimethylsphingosine on protein kinase C activity melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregationBIOMEMBRANE INST·Filed 1990·Granted Aug 11, 1992·52 cites·20 claims
- 0588US5248824AMethod of preparing N,N,N-trimethylsphingosineBIOMEMBRANE INST·Filed 1992·Granted Sep 28, 1993·35 cites·2 claims
- 0683US5331014AEffect of N,N,N-trimethylsphingosine on protein kinase-C activity; melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregationBIOMEMBRANE INST·Filed 1991·Granted Jul 19, 1994·45 cites·9 claims
- 0782US5663404ASphingosine-1-phosphate essentially free of L-threo isomerONCOMEMBRANE·Filed 1995·Granted Sep 2, 1997·48 cites·10 claims
- 0879US5877167AMethod for inhibition of cell motility by sphingosine-1-phosphate and its derivativesOTSUKA AMERICA PHARMACEUTICAL·Filed 1997·Granted Mar 2, 1999·42 cites·2 claims
- 0979US5627171ASphingosine-1-phosphate/trimethylsphingosine compositionONCOMEMBRANE INC·Filed 1994·Granted May 6, 1997·59 cites·5 claims
- 1072US5466716ALiposomal trimethylsphingosineBIOMEMBRANE INST·Filed 1994·Granted Nov 14, 1995·13 cites·4 claims
- 1165US2024277741A1Agent for preventing or ameliorating alzheimer's diseaseDAICEL CORP·Filed 2024·Application pending·0 cites
- 1262US5583160AMethylsphingosine used to treat apoptosisBIOMEMBRANE INST·Filed 1994·Granted Dec 10, 1996·25 cites·5 claims
- 1361US11998559B2Agent for preventing or ameliorating alzheimer's diseaseDAICEL CORP·Filed 2018·Granted Jun 4, 2024·0 cites·7 claims
- 1451US2021177778A1Exosome production promoterDAICEL CORP·Filed 2018·Application pending·0 cites
- 1547US5677189AMethod for quantifying sphingosine and for diagnosing platelet activationONCOMEMBRANE INC·Filed 1995·Granted Oct 14, 1997·13 cites·16 claims
- 1638US6031135ATrimethylsphingosine derivativesONCOMEMBRANE INC·Filed 1996·Granted Feb 29, 2000·3 cites·6 claims
- 1735US2014256793A1MEDICAMENT FOR DISEASES ASSOCIATED WITH AMYLOID beta AND SCREENING THEREOFUNIV HOKKAIDO NAT UNIV CORP·Filed 2012·Application pending·0 cites
- 1832US2012315658A1Amelioration of metabolic syndrome using physiological functions of sphingomyelin synthase sms2, or screening methods for ameliorating agentsMITSUTAKE SUSUMU·Filed 2010·Application pending·0 cites
- 1928US8889648B2Nucleic acid having an anti-metabolic syndrome effectMITSUTAKE SUSUMU·Filed 2011·Granted Nov 18, 2014·0 cites·13 claims
- 2027US5693620APlasmalopsychosines and plasmalocerebrosidesONCOMEMBRANE INC·Filed 1994·Granted Dec 2, 1997·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Yasuyuki Igarashi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →